Analyst Ratings for CVS Health
Portfolio Pulse from Benzinga Insights
CVS Health (NYSE:CVS) has received a mix of bullish and indifferent analyst ratings in the last quarter. The company's average price target has decreased by 12.76% from the previous average price target of $108.75 to $94.87.
July 07, 2023 | 3:00 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
CVS Health has seen a decrease in its average price target, indicating a potential decrease in stock price.
Analyst ratings are often used as an indicator of a stock's future performance. The decrease in CVS Health's average price target suggests that analysts are less optimistic about the company's future performance, which could lead to a decrease in its stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100